ORCHID PHARMA
|
ORCHID PHARMA Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹666 Cr | ₹560 Cr | ₹450 Cr | ₹484 Cr | ₹600 Cr |
Sales | ₹665 Cr | ₹559 Cr | ₹450 Cr | ₹483 Cr | ₹598 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹1.05 Cr | ₹0.77 Cr | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | - | - | ₹0.47 Cr | ₹0.69 Cr | ₹1.61 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹666 Cr | ₹560 Cr | ₹450 Cr | ₹484 Cr | ₹600 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-21 Cr | ₹-27 Cr | ₹-17 Cr | ₹-18 Cr | ₹27 Cr |
Raw Material Consumed | ₹406 Cr | ₹341 Cr | ₹246 Cr | ₹222 Cr | ₹263 Cr |
Opening Raw Materials | ₹43 Cr | ₹21 Cr | ₹30 Cr | ₹21 Cr | ₹42 Cr |
Purchases Raw Materials | ₹439 Cr | ₹362 Cr | ₹252 Cr | ₹230 Cr | ₹269 Cr |
Closing Raw Materials | ₹76 Cr | ₹43 Cr | ₹37 Cr | ₹30 Cr | ₹48 Cr |
Other Direct Purchases / Brought in cost | - | - | - | ₹0.47 Cr | ₹0.30 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹61 Cr | ₹53 Cr | ₹39 Cr | ₹47 Cr | ₹49 Cr |
Electricity & Power | ₹61 Cr | ₹53 Cr | ₹39 Cr | ₹47 Cr | ₹49 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹65 Cr | ₹63 Cr | ₹67 Cr | ₹75 Cr | ₹82 Cr |
Salaries, Wages & Bonus | ₹54 Cr | ₹49 Cr | ₹56 Cr | ₹63 Cr | ₹66 Cr |
Contributions to EPF & Pension Funds | ₹4.25 Cr | ₹8.49 Cr | ₹5.02 Cr | ₹5.49 Cr | ₹8.10 Cr |
Workmen and Staff Welfare Expenses | ₹6.60 Cr | ₹5.43 Cr | ₹5.70 Cr | ₹6.58 Cr | ₹8.03 Cr |
Other Employees Cost | - | - | - | - | - |
Other Manufacturing Expenses | ₹36 Cr | ₹33 Cr | ₹29 Cr | ₹53 Cr | ₹56 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | ₹0.01 Cr | ₹0.34 Cr |
Repairs and Maintenance | ₹17 Cr | ₹14 Cr | ₹13 Cr | ₹3.86 Cr | ₹20 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹19 Cr | ₹19 Cr | ₹16 Cr | ₹49 Cr | ₹36 Cr |
General and Administration Expenses | ₹14 Cr | ₹13 Cr | ₹18 Cr | ₹44 Cr | ₹31 Cr |
Rent , Rates & Taxes | ₹0.99 Cr | ₹1.41 Cr | ₹2.78 Cr | ₹8.20 Cr | ₹3.45 Cr |
Insurance | ₹3.96 Cr | ₹4.23 Cr | ₹5.06 Cr | ₹8.97 Cr | ₹6.08 Cr |
Printing and stationery | - | - | ₹0.42 Cr | ₹0.49 Cr | ₹0.67 Cr |
Professional and legal fees | ₹4.46 Cr | ₹4.04 Cr | ₹7.19 Cr | ₹14 Cr | ₹7.42 Cr |
Traveling and conveyance | ₹0.51 Cr | ₹0.20 Cr | ₹0.10 Cr | ₹0.37 Cr | ₹0.42 Cr |
Other Administration | ₹4.35 Cr | ₹3.15 Cr | ₹2.79 Cr | ₹12 Cr | ₹13 Cr |
Selling and Distribution Expenses | ₹14 Cr | ₹22 Cr | ₹13 Cr | ₹8.14 Cr | ₹10 Cr |
Advertisement & Sales Promotion | ₹0.60 Cr | ₹0.10 Cr | ₹0.16 Cr | ₹0.58 Cr | ₹1.03 Cr |
Sales Commissions & Incentives | ₹6.75 Cr | ₹12 Cr | ₹4.05 Cr | ₹2.85 Cr | ₹4.47 Cr |
Freight and Forwarding | ₹6.98 Cr | ₹11 Cr | ₹9.25 Cr | ₹4.71 Cr | ₹4.85 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹6.22 Cr | ₹7.22 Cr | ₹3.59 Cr | ₹23 Cr | ₹94 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | ₹1.19 Cr | ₹3.67 Cr | ₹1.33 Cr | ₹2.67 Cr | ₹9.30 Cr |
Losson disposal of fixed assets(net) | ₹0.16 Cr | - | ₹0.07 Cr | - | - |
Losson foreign exchange fluctuations | - | - | - | ₹18 Cr | ₹68 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹4.87 Cr | ₹3.56 Cr | ₹2.19 Cr | ₹2.59 Cr | ₹17 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹582 Cr | ₹505 Cr | ₹399 Cr | ₹454 Cr | ₹612 Cr |
Operating Profit (Excl OI) | ₹84 Cr | ₹55 Cr | ₹51 Cr | ₹30 Cr | ₹-12 Cr |
Other Income | ₹19 Cr | ₹9.00 Cr | ₹15 Cr | ₹24 Cr | ₹17 Cr |
Interest Received | ₹0.62 Cr | ₹0.42 Cr | ₹0.73 Cr | ₹24 Cr | ₹15 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | ₹0.94 Cr | - | - | ₹0.09 Cr | ₹0.00 Cr |
Profits on sale of Investments | ₹0.02 Cr | ₹0.51 Cr | ₹1.04 Cr | - | - |
Provision Written Back | - | - | ₹8.57 Cr | - | - |
Foreign Exchange Gains | ₹5.20 Cr | ₹7.58 Cr | ₹3.49 Cr | ₹0.60 Cr | - |
Others | ₹13 Cr | ₹0.49 Cr | ₹1.38 Cr | ₹-0.58 Cr | ₹1.84 Cr |
Operating Profit | ₹104 Cr | ₹64 Cr | ₹66 Cr | ₹54 Cr | ₹5.11 Cr |
Interest | ₹33 Cr | ₹33 Cr | ₹52 Cr | ₹6.23 Cr | ₹6.69 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹15 Cr | ₹19 Cr | ₹39 Cr | ₹0.12 Cr | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹0.68 Cr | ₹1.44 Cr | ₹0.87 Cr | ₹2.07 Cr | ₹6.39 Cr |
Other Interest | ₹18 Cr | ₹13 Cr | ₹12 Cr | ₹4.04 Cr | ₹0.30 Cr |
PBDT | ₹71 Cr | ₹30 Cr | ₹14 Cr | ₹48 Cr | ₹-1.58 Cr |
Depreciation | ₹55 Cr | ₹87 Cr | ₹109 Cr | ₹118 Cr | ₹130 Cr |
Profit Before Taxation & Exceptional Items | ₹16 Cr | ₹-57 Cr | ₹-95 Cr | ₹-70 Cr | ₹-132 Cr |
Exceptional Income / Expenses | ₹39 Cr | - | - | - | ₹201 Cr |
Profit Before Tax | ₹55 Cr | ₹-57 Cr | ₹-95 Cr | ₹-70 Cr | ₹69 Cr |
Provision for Tax | - | - | - | - | - |
Current Income Tax | - | - | - | - | - |
Deferred Tax | - | - | - | - | - |
Other taxes | - | - | - | - | - |
Profit After Tax | ₹55 Cr | ₹-57 Cr | ₹-95 Cr | ₹-70 Cr | ₹69 Cr |
Extra items | ₹-6.78 Cr | ₹58 Cr | ₹-21 Cr | ₹-61 Cr | - |
Minority Interest | - | - | - | - | - |
Share of Associate | ₹-2.15 Cr | ₹-3.52 Cr | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹46 Cr | ₹-1.95 Cr | ₹-117 Cr | ₹-131 Cr | ₹69 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹-2,314 Cr | ₹-2,314 Cr | ₹-2,198 Cr | ₹-1,870 Cr | ₹-1,940 Cr |
Appropriations | ₹-2,268 Cr | ₹-2,316 Cr | ₹-2,314 Cr | ₹-2,001 Cr | ₹-1,871 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹0.23 Cr | ₹-1.46 Cr | ₹-0.60 Cr | ₹-87 Cr | ₹-0.90 Cr |
Equity Dividend % | - | - | - | - | - |
Earnings Per Share | ₹11.35 | ₹-0.48 | ₹-28.55 | ₹-32.11 | ₹7.80 |
Adjusted EPS | ₹11.35 | ₹-0.48 | ₹-28.55 | ₹-32.11 | ₹7.80 |
Compare Income Statement of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹6,763.4 Cr | -8% | -21.5% | 102.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,303.0 Cr | 1.4% | -4.1% | 32.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹143,389.0 Cr | -4.2% | -5.1% | 59.6% | Stock Analytics | |
CIPLA | ₹114,645.0 Cr | -2.2% | -7.3% | 0.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,449.5 Cr | -7.1% | -13.8% | 8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹91,587.4 Cr | -6.4% | -5.2% | 31.2% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | -8% |
-21.5% |
102.8% |
SENSEX | 0.1% |
-3.6% |
7.9% |
You may also like the below Video Courses